Earnings Preview: Exelixis (EXEL) Q1 Earnings Expected to DeclineZacks Investment Research • 04/28/20
Exelixis, Bristol-Myers stocks get a boost from upbeat trial results of a Kidney cancer treatmentMarket Watch • 04/20/20
Exelixis, Inc. (EXEL) CEO Mike Morrissey Presents at Barclays Global Healthcare Conference 2020 (Transcript)Seeking Alpha • 03/10/20
Exelixis, Inc. (EXEL) CEO Michael Morrissey on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/26/20
Exelixis (EXEL) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research • 02/11/20
Exelixis Reports Positive Results in Metastatic Castration-Resistant Prostate Cancer StudyThe Motley Fool • 02/11/20